Related Experiment Video
Updated: Apr 26, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Report from the Melanoma Independent Board First Melanoma MIB Conference, 21-22 October 2013
A Testori1, P Ascierto2, V Chiarion Sileni3
1European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy.
Abstract:
The Melanoma Independent Board (MIB) held its first conference from 21 to 22 October, 2013, in Rome, Italy. Like the MIB itself, the conference brought together specialists from all aspects of cancer care: doctors, patient associations, journalists, and representatives from local government, hospitals, and pharma to encourage an interdisciplinary discussion on the future of melanoma. It was hoped that the conference would be an opportunity for all participants to see and understand each other's points of view. In memoriam of melanoma pioneer Natalie Cascinelli, the conference focussed on innovation and sustainability as well as the latest drug developments.

